[ Price : $8.95]
Federal Register Notice: FDA seeks comments on information collection requirements for device recall authority.[ Price : $8.95]
Federal Register Notice: FDA determines that Travatan 0.004% was not withdrawn from sale for reasons of safety or effectiveness.[ Price : $8.95]
Two congressmen ask the Government Accountability Office to research and report on dietary supplement adverse event reporting.[ Price : $8.95]
At a Senate hearing, CDRH director Jeff Shuren provides his perspective on how to reduce rising medical device approval times.[ Price : $8.95]
CooperVision says it is now recalling some lots of its Avaira Sphere contact lenses.[ Price : $8.95]
FDA approves Incytes Jakafi dosed twice daily to treat myelofibrosis.[ Price : $8.95]
FDA approves Merz Aesthetics Belotero dermal filler for correcting moderate to severe nasolabial folds.[ Price : $8.95]
Tufts University researchers say there is considerable evidence to support greater restrictions on non-therapeutic use of antibiot...